Renaisso Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 13028.90%
- Profit Growth -88.69%
- Ebitda -109.91%
- Net Worth -174.09%
- Total Assets 44.48%
About Renaisso Pharma
Renaisso Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 May 2018 (Six years and nine months 16 days old ). Its registered office is in Barabanki, Uttar Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Srivastava, Deep Verma, and Udai Singh serve as directors at the Company.
Company Details
-
Location
Barabanki, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2018PTC103874
-
Company No.
103874
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 May 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Renaisso Pharma Private Limited offer?
Renaisso Pharma Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Facial Kit, Hair Oil, Bleaching Cream, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics.
Who are the key members and board of directors at Renaisso Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Srivastava
|
Director | 03-May-2018 | Current |
|
Deep Verma
|
Director | 03-May-2018 | Current |
|
Udai Singh
|
Director | 03-May-2018 | Current |
Financial Performance of Renaisso Pharma.
Renaisso Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 13028.9% increase. The company also saw a substantial fall in profitability, with a 88.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 174.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renaisso Pharma?
Unlock access to Renaisso Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nexagrow Services Private LimitedAjay Srivastava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renaisso Pharma?
Unlock and access historical data on people associated with Renaisso Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renaisso Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renaisso Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.